This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez-Tudela, J. L.
Right arrow Articles by Sanchez, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez-Tudela, J. L.
Right arrow Articles by Sanchez, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 09 1996, 1998-2003, Vol 40, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans

JL Rodriguez-Tudela, J Berenguer, JV Martinez-Suarez and R Sanchez
Unidad de Micologia, Instituto de Salud Carlos III, Majadahonda, Spain. jlrodrgz@isciii.es

The National Committee for Clinical Laboratory Standards has proposed a reference broth macrodilution method for in vitro antifungal susceptibility testing of yeasts (the M27-P method). This method is cumbersome and time-consuming and includes MIC endpoint determination by visual and subjective inspection of growth inhibition after 48 h of incubation. An alternative microdilution procedure was compared with the M27-P method for determination of the amphotericin B, flucytosine, and fluconazole susceptibilities of 8 American Type Culture Collection strains (6 of them were quality control or reference strains) and 50 clinical isolates of candida albicans. This microdilution method uses as culture medium RPMI 1640 supplemented with 18 g of glucose per liter (RPMI-2% glucose). Preparation of drugs, basal medium, and inocula was done by following the recommendations of the National Committee for Clinical Laboratory Standards. The MIC endpoint was calculated objectively from the turbidimetric data read at 24 h. Increased growth of C. albicans in RPMI-2% glucose and its spectrophotometric reading allowed for the rapid (24 h) and objective calculation of MIC endpoints compared with previous microdilution methods with standard RPMI 1640. Nevertheless, good agreement was shown between the M27-P method and this microdilution test. The MICs obtained for the quality control or reference strains by the microdilution method were in the ranges published for those strains. For clinical isolates, the percentages of agreement were 100% for amphotericin B and fluconazole and 98.1% for flucytosine. These data suggest that this microdilution method may serve as a less subjective and more rapid alternative to the M27-P method for antifungal susceptibility testing of yeasts.


This article has been cited by other articles:

  • Benincasa, M., Scocchi, M., Pacor, S., Tossi, A., Nobili, D., Basaglia, G., Busetti, M., Gennaro, R. (2006). Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother 58: 950-959 [Abstract] [Full Text]  
  • Munoz, P., Sanchez-Somolinos, M., Alcala, L., Rodriguez-Creixems, M., Pelaez, T., Bouza, E. (2005). Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J Antimicrob Chemother 55: 188-193 [Abstract] [Full Text]  
  • Kleymann, G., Werling, H.-O. (2004). A Generally Applicable, High-Throughput Screening-Compatible Assay to Identify, Evaluate, and Optimize Antimicrobial Agents for Drug Therapy. J Biomol Screen 9: 578-587 [Abstract]  
  • Warn, P. A., Sharp, A., Guinea, J., Denning, D. W. (2004). Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida. J Antimicrob Chemother 53: 743-749 [Abstract] [Full Text]  
  • Moore, C. B., Walls, C. M., Denning, D. W. (2003). Comparison of three methods for in vitro susceptibility testing of Candida species with flucytosine. J Antimicrob Chemother 51: 297-304 [Abstract] [Full Text]  
  • Dannaoui, E., Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., Verweij, P. E., the Eurofung Network, (2003). In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51: 45-52 [Abstract] [Full Text]  
  • Rambali, B., Fernandez, J. A., Van Nuffel, L., Woestenborghs, F., Baert, L., Massart, D. L., Odds, F. C. (2001). Susceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables. J Antimicrob Chemother 48: 163-177 [Abstract] [Full Text]  
  • Rodriguez-Tudela, J. L., Cuenca-Estrella, M., Diaz-Guerra, T. M., Mellado, E. (2001). Standardization of Antifungal Susceptibility Variables for a Semiautomated Methodology. J. Clin. Microbiol. 39: 2513-2517 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Mellado, E., Díaz-Guerra, T. M., Monzón, A., Rodríguez-Tudela, J. L. (2001). Azasordarins: Susceptibility of Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida spp. to GW 471558. Antimicrob. Agents Chemother. 45: 1905-1907 [Abstract] [Full Text]  
  • Cuenca-Estrella, M., Díaz-Guerra, T. M., Mellado, E., Rodríguez-Tudela, J. L. (2001). Influence of Glucose Supplementation and Inoculum Size on Growth Kinetics and Antifungal Susceptibility Testing of Candida spp.. J. Clin. Microbiol. 39: 525-532 [Abstract] [Full Text]  
  • Rodríguez-Tudela, J. L., Martín-Díez, F., Cuenca-Estrella, M., Rodero, L., Carpintero, Y., Gorgojo, B. (2000). Influence of Shaking on Antifungal Susceptibility Testing of Cryptococcus neoformans: a Comparison of the NCCLS Standard M27A Medium, Buffered Yeast Nitrogen Base, and RPMI-2% Glucose. Antimicrob. Agents Chemother. 44: 400-404 [Abstract] [Full Text]  
  • Arthington-Skaggs, B. A., Jradi, H., Desai, T., Morrison, C. J. (1999). Quantitation of Ergosterol Content: Novel Method for Determination of Fluconazole Susceptibility of Candida albicans. J. Clin. Microbiol. 37: 3332-3337 [Abstract] [Full Text]  
  • Hong, S. Y., Oh, J. E., Lee, K. H. (1999). In Vitro Antifungal Activity and Cytotoxicity of a Novel Membrane-Active Peptide. Antimicrob. Agents Chemother. 43: 1704-1707 [Abstract] [Full Text]  
  • Nguyen, M. H., Yu, C. Y. (1999). Influence of Incubation Time, Inoculum Size, and Glucose Concentrations on Spectrophotometric Endpoint Determinations for Amphotericin B, Fluconazole, and Itraconazole. J. Clin. Microbiol. 37: 141-145 [Abstract] [Full Text]  
  • Hong, S. Y., Oh, J. E., Kwon, M. y., Choi, M. J., Lee, J. H., Lee, B. L., Moon, H. M., Lee, K. H. (1998). Identification and Characterization of Novel Antimicrobial Decapeptides Generated by Combinatorial Chemistry. Antimicrob. Agents Chemother. 42: 2534-2541 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»